Researchers have identified six key genes associated with both schizophrenia and brain aging, suggesting that inflammation- and coagulation-related pathways represent shared biological features of the two conditions. Schizophrenia is linked to accelerated brain aging, which may stem from reduced synaptic gene expression in neuron-astrocyte interactions in a process resembling normal brain aging, though the precise connecting mechanisms have remained unclear.
To examine the molecular links between the conditions, the researchers selected key candidate genes from schizophrenia datasets and the AgeAnno database. The study utilized the XGBoost machine learning algorithm to validate differential expression genes derived from the schizophrenia data.
Single-gene Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were conducted to evaluate the biological roles and pathways of the genes. Enrichment analysis subsequently highlighted coagulation cascades and inflammatory pathways as shared molecular characteristics between schizophrenia and brain aging.
The analysis identified six key genes associated with both schizophrenia and brain aging, highlighting their potential as candidate biomarkers and regulators. Among these six genes, DYNC1I1, HIVEP2, LGI2, PPP3CB, and SLC24A2 were downregulated, whereas MT2A was upregulated.
The researchers also evaluated immune infiltration to reflect the immune microenvironment within the brains of schizophrenia patients. This analysis revealed that specific immune cell populations, including type 1 T helper cells, CD56dim natural killer cells, and activated B cells, may be associated with immune dysregulation in schizophrenia.
To explore gene expression regulation, the authors constructed gene-microRNA and transcription factor-gene interaction networks, identifying several candidate regulatory factors. The researchers further suggest that zinc finger proteins may be involved in pathways related to the conditions, noting that these preliminary findings provide initial insights into shared biological processes.
The investigation focused on the relationship between schizophrenia and accelerated brain aging, examining the hypothesis that this acceleration may stem from reduced synaptic gene expression in neuron-astrocyte interactions. While this process shows similarities to normal brain aging, the precise biological mechanisms that connect schizophrenia and brain aging have remained unclear. To address this question, researchers structured their analysis around candidate gene selection drawn from schizophrenia datasets alongside the AgeAnno database. Validation of differential expression genes derived from the schizophrenia data was carried out using the XGBoost algorithm, providing the computational basis for identifying key genes associated with the two conditions.
To explore the biological roles and functional pathways of the selected genes, the study performed single-gene Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. Through this enrichment analysis, the authors determined that coagulation cascades and inflammation represent shared features between schizophrenia and brain aging. Rather than acting through entirely separate pathways, brain aging and schizophrenia share a common dysregulation in inflammation and coagulation cascades, suggesting that these inflammation-related and coagulation-related pathways serve as shared biological features linking the psychiatric condition and the aging brain.
Across the analysis, six key genes were identified as potential regulators and candidate biomarkers associated with both schizophrenia and brain aging. The study documented distinct directional changes in expression among these six genes: DYNC1I1, HIVEP2, LGI2, PPP3CB, and SLC24A2 were downregulated, whereas MT2A was upregulated. Identifying these specific downregulated and upregulated genes highlights their potential utility as candidate biomarkers and potential regulators for both conditions, clarifying the specific genetic components that participate in the molecular overlap between schizophrenia and brain aging.
The research also assessed immune infiltration to reflect the immune microenvironment within the brain in schizophrenia patients. This assessment revealed that specific immune cell types may be associated with immune dysregulation in schizophrenia. In particular, the study identified type 1 T helper cells, CD56dim natural killer cells, and activated B cells as immune cell populations that may be linked to immune dysregulation in the condition. These observations connect the brain immune microenvironment in schizophrenia with broader immune dysregulation, complementing the inflammatory pathways identified through enrichment analysis.
To examine how gene expression is regulated in these conditions, the investigators constructed gene-microRNA interaction networks and transcription factor-gene interaction networks. These interaction analyses identified several candidate regulatory factors that may be associated with schizophrenia and brain aging. Furthermore, the findings suggest that zinc finger proteins may be involved in the molecular pathways related to schizophrenia and brain aging, pointing to a regulatory component that may participate in the shared mechanisms governing both conditions.
The researchers noted that these findings provide preliminary insights into the biological processes that may be shared between schizophrenia and brain aging, rather than definitive mechanistic proof. While the study highlights the potential of the six key genes as candidate biomarkers and points to shared dysregulation in inflammation and coagulation cascades, the exact connecting mechanisms between schizophrenia and accelerated brain aging remain to be fully resolved. Consequently, the identified genes, regulatory factors, and immune cell associations represent initial candidate targets for understanding shared molecular mechanisms and potential intervention.
Subject of Research: Shared molecular mechanisms of schizophrenia and brain aging
Article Title: The Shared Molecular Mechanisms and Intervention of Schizophrenia and Brain Aging
Article References: Sun, Y., Yang, M., Yan, F., Chen, J., & Yi, C. (2026). The Shared Molecular Mechanisms and Intervention of Schizophrenia and Brain Aging. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01800-z
Image Credits: AI Generated
DOI: 10.1007/s10571-026-01800-z
Keywords: schizophrenia, brain aging, differential gene expression, inflammation, coagulation cascades, biomarkers, immune infiltration, zinc finger proteins, Shared, Molecular, Mechanisms, Intervention
News Source: Juliet Wilcox. (November 9, 2026). Study Identifies Shared Genes and Pathways in Schizophrenia and Brain Aging. Scienmag.
